查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
北美深腦模擬市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶
市場調查報告書
商品編碼
1402488

北美深腦模擬市場預測至 2030 年 - 區域分析 - 按產品、應用和最終用戶

North America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 82 Pages | 訂單完成後即時交付

價格

北美深腦模擬市場預計將從2022年的2.8286億美元成長到2030年的5.4978億美元。預計2022年至2030年CAGR為8.7%。

神經系統疾病盛行率上升推動北美深部腦部模擬市場

老年人群易患神經系統疾病。神經病變、帕金森氏症、阿茲海默症和肌張力失調是影響老年人的最常見的神經系統疾病。根據美國國立衛生研究院 (NIH) 的數據，全球 8.5% 的人口（即約 6.17 億人）年齡在 65 歲及以上。美國和加拿大等國家與老年人口成長相關的運動障礙和精神疾病盛行率很高。根據帕金森基金會的數據，帕金森症狀在平均 60 歲的人群中很常見。加拿大心理學協會指出，大約 2% 的人口患有強迫症 (OCD)。根據世界衛生組織 (WHO) 的數據，神經系統疾病佔全球疾病負擔的 6.3%，是全世界死亡的主要原因之一。此外，據報導，已開發國家13.2%的死亡和中低收入國家16.8%的死亡是由於神經系統疾病造成的。高死亡率和疾病負擔使得臨床迫切需要整合深部腦部刺激器 (DBS) 等長期解決方案。因此，人們對神經系統疾病負擔的認知不斷增強、老年人口不斷成長以及神經系統疾病盛行率不斷上升，推動了對深部腦部刺激器作為治療方法的需求。

北美深腦模擬市場概況

帕金森氏症（PD）等神經系統疾病的盛行率不斷上升，人們對神經系統疾病的認知不斷提高，積極的研究成果以及對開發經顱刺激器的投資不斷增加是推動美國深部腦部刺激市場整體成長的主要因素。據觀察，深部腦部刺激（DBS）裝置可有效控制與巴金森氏症相關的震顫。多巴胺水平低和其他遺傳因素是帕金森氏症的主要原因。根據阿茲海默症協會發表的一項題為「2022年阿茲海默症事實與數據」的研究顯示，2022年，近650萬65歲及以上的美國人被發現患有阿茲海默症病，預計到2060年，這一數字將增至1380萬。進步和新產品的推出推動了美國深部腦部刺激市場的成長。 2020 年 1 月，雅培的 Infinity DBS 系統獲得美國食品藥物管理局 (FDA) 批准用於治療帕金森氏症。該系統可以對大腦的特定區域（稱為內蒼白球（GPi））進行有針對性的治療，該區域與帕金森氏症的症狀有關。美國 FDA 於 2017 年 12 月批准 Verses 腦深部刺激裝置系統用於治療巴金森氏症，供波士頓科學公司使用。根據帕金森基金會統計，美國約有100萬人患有帕金森氏症，預計到2030年將增加到120萬人。因此，神經系統疾病盛行率的不斷上升和技術進步推動了北美深部腦部模擬市場的成長在美國。

北美深腦模擬市場收入及 2030 年預測（百萬美元）

北美深腦模擬市場細分

北美深腦模擬市場分為產品、應用、最終用戶和國家。

根據產品，北美深部腦部模擬市場分為單通道深部腦部刺激器、雙通道深部腦部刺激器以及軟體和配件。 2022年，雙通道深部腦部刺激器細分市場在北美深部腦部模擬市場中佔據最大佔有率。

根據應用，北美深部腦部模擬市場分為帕金森氏症、震顫、肌張力失調、癲癇、阿茲海默症等。 2022年，帕金森氏症領域在北美深部腦部模擬市場中佔據最大佔有率。

根據最終用戶，北美深部腦部模擬市場分為醫院、神經科診所、門診手術中心等。 2022年，醫院領域在北美深腦模擬市場中佔據最大佔有率。

依國家分類，北美深腦模擬市場分為美國、加拿大、墨西哥。 2022年，美國在北美深腦模擬市場中佔據最大佔有率。

雅培實驗室 (Abbott Laboratories)、波士頓科學公司 (Boston Scientific Corp)、美敦力公司 (Medtronic Plc) 和 Newronika SpA 是北美深腦模擬市場的一些領先公司。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第 2 章：執行摘要

  • 重要見解
  • 北美深部腦部刺激市場（按地區）

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美深腦模擬市場格局

  • 概述
  • 北美 PEST 分析
  • 比較分析
    • 深部腦部刺激與損傷手術的比較
    • 神經系統疾病的損傷手術
    • 2022 年按國家進行的深部腦部刺激手術

第 5 章：北美深腦模擬市場 - 主要產業動態

  • 主要市場促進因素：
    • 神經系統疾病盛行率上升
    • 微創手術的需求不斷增加
  • 市場限制
    • 與深部腦部刺激相關的副作用
  • 市場機會
    • 深部腦部刺激的技術進步與批准
  • 未來的趨勢
    • 不斷增加的研發活動
  • 影響分析

第 6 章：深腦模擬市場 - 北美市場分析

  • 北美深腦模擬市場收入，2022 - 2030

第 7 章：北美深腦模擬市場 - 收入和 2030 年預測 - 按產品

  • 概述
  • 2022 年及 2030 年北美深腦模擬市場收入佔有率，按產品分類 (%)
  • 單通道深部腦部刺激器
  • 雙通道深部腦部刺激器
  • 軟體及配件

第 8 章：北美深腦模擬市場 - 2030 年收入與預測 -按應用

  • 概述
  • 2022 年和 2030 年北美深腦模擬市場收入佔有率，按應用分類 (%)
  • 帕金森氏症
  • 震顫
  • 阿茲海默氏症
  • 肌張力失調
  • 癲癇
  • 其他

第 9 章：北美深腦模擬市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年北美深腦模擬市場收入佔有率（按最終用戶分類）（%）
  • 醫院
  • 神經內科診所
  • 門診手術中心
  • 其他

第 10 章：北美深腦模擬市場 - 國家分析

  • 概述
      • 北美深腦模擬市場（按國家）
      • 美國
      • 加拿大
      • 墨西哥

第 11 章：Covid-19 前後的影響

  • Covid-19 前後的影響

第 12 章：深腦模擬市場產業格局

  • 概述
  • 深部腦部刺激市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：北美深腦模擬市場，主要公司概況

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Newronika SpA

第 14 章：附錄

  • 關於我們
  • 專業術語
Product Code: BMIRE00029026

The North America deep brain simulation market is expected to grow from US$ 282.86 million in 2022 to US$ 549.78 million by 2030. It is estimated to grow at a CAGR of 8.7% from 2022 to 2030.

Rising Prevalence of Neurological Disorders Drive North America Deep Brain Simulation Market

The geriatric population is susceptible to neurological diseases. Neuropathy, Parkinson's disease, Alzheimer's disease, and dystonia are among the most common neurological disorders affecting older people. According to the National Institutes of Health (NIH), 8.5% of the world's population (i.e., around 617 million people) are 65 and above. Countries such as the US and Canada have high prevalence rates of movement disorders and psychiatric disorders associated with growing geriatric populations. According to the Parkinson's Foundation, Parkinson's symptoms are common at an average age of 60. The Canadian Psychological Association states that about 2% of the population suffers from obsessive-compulsive disorder (OCD). According to the World Health Organization (WHO), neurological diseases contribute 6.3% to the global disease burden and are one of the leading causes of death across the world. In addition, 13.2% of deaths in developed countries and 16.8% in low- and middle-income countries are reported due to neurological diseases. High mortality and disease burden necessitate the clinical urgency for integrating long-term solutions such as deep brain stimulators (DBS). Therefore, growing awareness regarding the burden of neurological disorders, the growing geriatric population, and the increasing prevalence of neurological diseases propel the demand for deep brain stimulators as a therapy.

North America Deep Brain Simulation Market Overview

The rising prevalence of neurological diseases such as Parkinson's disease (PD), increasing awareness about neurological disorders, positive research results, and growing investments in developing transcranial stimulators are among the main factors driving the overall deep brain stimulation market growth in the US. Deep brain stimulation (DBS) devices have been observed to be effective in controlling the tremors associated with Parkinson's disease. Low dopamine levels and other genetic factors are among the main causes of Parkinson's disease. According to a study titled "2022 Alzheimer's disease facts and figures" published in the Alzheimer's Association, nearly 6.5 million Americans aged 65 and above were found to have Alzheimer's disease in 2022, and that number is projected to rise to 13.8 million by 2060. Technological advancements and new product launches drive the growth of the US deep brain stimulation market. In January 2020, Abbott's Infinity DBS System received US Food and Drug Administration (FDA) approval for treating Parkinson's disease. This system allows for the targeted treatment of a specific area of the brain, called the inner globus pallidus (GPi), which is associated with the symptoms of Parkinson's disease. The US FDA approved the Verses deep brain stimulation device system for treating Parkinson's disease in December 2017 for use by Boston Scientific Corporation. According to the Parkinson's Foundation, around 1 million people in the US are suffering from Parkinson's disease, which is expected to increase to 1.2 million by 2030. Therefore, the increasing prevalence of neurological diseases and technological advancements fuel the North America deep brain simulation market growth in the US.

North America Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Million)

North America Deep Brain Simulation Market Segmentation

The North America deep brain simulation market is segmented into product, application, end user, and country.

Based on product, the North America deep brain simulation market is segmented into single channel deep brain stimulator, dual channel deep brain stimulator, and software and accessories. In 2022, the dual channel deep brain stimulator segment registered the largest share in the North America deep brain simulation market.

Based on application, the North America deep brain simulation market is segmented into Parkinson's disease, tremor, dystonia, epilepsy, Alzheimer's disease, and others. In 2022, the Parkinson's disease segment registered the largest share in the North America deep brain simulation market.

Based on end user, the North America deep brain simulation market is segmented into hospitals, neurology clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the largest share in the North America deep brain simulation market.

Based on country, the North America deep brain simulation market is segmented into the US, Canada, Mexico. In 2022, the US registered the largest share in the North America deep brain simulation market.

Abbott Laboratories, Boston Scientific Corp, Medtronic Plc, and Newronika SpA are some of the leading companies operating in the North America deep brain simulation market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America deep brain simulation market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the North America deep brain simulation market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth North America market trends and outlook coupled with the factors driving the deep brain simulation market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 North America Deep Brain Stimulation Market, by Region (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Deep Brain Simulation Market Landscape

  • 4.1 Overview
  • 4.2 North America PEST Analysis
  • 4.3 Comparison Analysis
    • 4.3.1 Comparison of Deep Brain Stimulation and Lesioning Procedures
    • 4.3.2 Lesioning Procedures in Neurological Disorders
    • 4.3.3 Deep Brain Stimulation Surgical Procedures Performed in 2022, By Country

5. North America Deep Brain Simulation Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Rising Prevalence of Neurological Disorders
    • 5.1.2 Increasing Demand for Minimally Invasive Surgery
  • 5.2 Market Restraints
    • 5.2.1 Side Effects Associated with Deep Brain Stimulation
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements and Approvals in Deep Brain Stimulation
  • 5.4 Future Trends
    • 5.4.1 Growing Research and Development Activities
  • 5.5 Impact Analysis

6. Deep Brain Simulation Market - North America Market Analysis

  • 6.1 North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030

7. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Single Channel Deep Brain Stimulator
    • 7.3.1 Overview
    • 7.3.2 Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Dual Channel Deep Brain Stimulator
    • 7.4.1 Overview
    • 7.4.2 Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Software and Accessories
    • 7.5.1 Overview
    • 7.5.2 Software and Accessories: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Parkinson's Disease
    • 8.3.1 Overview
    • 8.3.2 Parkinson's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Tremor
    • 8.4.1 Overview
    • 8.4.2 Tremor: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Alzheimer's Disease
    • 8.5.1 Overview
    • 8.5.2 Alzheimer's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Dystonia
    • 8.6.1 Overview
    • 8.6.2 Dystonia: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Epilepsy
    • 8.7.1 Overview
    • 8.7.2 Epilepsy: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Deep Brain Simulation Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Neurology Clinics
    • 9.4.1 Overview
    • 9.4.2 Neurology Clinics: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Ambulatory Surgical Centers
    • 9.5.1 Overview
    • 9.5.2 Ambulatory Surgical Centers: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Deep Brain Simulation Market - Country Analysis

  • 10.1 Overview
      • 10.1.1.1 North America Deep Brain Simulation Market, by Country
      • 10.1.1.2 US
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 US Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 US Deep Brain Simulation Market, by Product
        • 10.1.1.2.4 US Deep Brain Simulation Market, by Application
        • 10.1.1.2.5 US Deep Brain Simulation Market, by End User
      • 10.1.1.3 Canada
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 Canada Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 Canada Deep Brain Simulation Market, by Product
        • 10.1.1.3.4 Canada Deep Brain Simulation Market, by Application
        • 10.1.1.3.5 Canada Deep Brain Simulation Market, by End User
      • 10.1.1.4 Mexico
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Mexico Deep Brain Simulation Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Mexico Deep Brain Simulation Market, by Product
        • 10.1.1.4.4 Mexico Deep Brain Simulation Market, by Application
        • 10.1.1.4.5 Mexico Deep Brain Simulation Market, by End User

11. Pre & Post Covid-19 Impact

  • 11.1 Pre & Post Covid-19 Impact

12. Deep Brain Simulation Market Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Deep Brain Stimulation Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. North America Deep Brain Simulation Market, Key Company Profiles

  • 13.1 Abbott Laboratories
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Medtronic Plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Boston Scientific Corp
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Newronika SpA
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. North America Deep Brain Simulation Market Segmentation
  • Table 2. Comparison of Deep Brain Stimulation and Lesioning Procedures
  • Table 3. Deep Brain Stimulation Surgical Procedures Performed in 2022, by Country.
  • Table 4. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 5. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 7. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 8. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 9. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 10. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Product
  • Table 11. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 12. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 13. Recent Organic Growth Strategies in Deep Brain Stimulation Market
  • Table 14. Recent Inorganic Growth Strategies in the North America deep brain simulation market
  • Table 15. Glossary of Terms, North America Deep Brain Simulation Market

List Of Figures

  • Figure 1. North America Deep Brain Simulation Market Segmentation, By Country
  • Figure 2. North America - PEST Analysis
  • Figure 3. North America Deep Brain Simulation Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Deep Brain Simulation Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. North America Deep Brain Simulation Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Single Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Dual Channel Deep Brain Stimulator: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Software and Accessories: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. North America Deep Brain Simulation Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 11. Parkinson's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Tremor: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Alzheimer's Disease: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Dystonia: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Epilepsy: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. North America Deep Brain Simulation Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 18. Hospitals: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Neurology Clinics: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: North America Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Deep Brain Simulation Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America Deep Brain Simulation Market, 2022 ($Mn)
  • Figure 23. North America Deep Brain Simulation Market, By Key Countries, 2022 And 2030 (%)
  • Figure 24. US Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 25. Canada Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico Deep Brain Simulation Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 27. Pre & Post Covid-19 Impact
  • Figure 28. Growth Strategies in Deep Brain Stimulation Market